World's Leading Doctors In CCSVI Available For Patient And Media Meet & Greet At ISNVD Gala Dinner - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
World's Leading Doctors In CCSVI Available For Patient And Media Meet & Greet At ISNVD Gala Dinner


World's Leading Doctors In CCSVI Available For Patient And Media Meet & Greet At ISNVD Gala Dinner

PR Newswire

SAN FRANCISCO, Jan. 21, 2014 /PRNewswire-USNewswire/ -- The International Society for Neurovascular Diseases (ISNVD.org) and The Annette Funicello Research Fund for Neurological Diseases today announced a co-hosted meet & greet with the world's leading doctors in CCSVI research, a revolutionary new treatment for Multiple Sclerosis. This is a never before seen opportunity for physicians, patients and journalists to meet with top doctors in an informal, face-to-face setting.

What: Direct discussions with top doctors in CCSVI research. Doctors from around the globe will be mingling with patients, journalists and medical professionals at a gala dinner and reception held in conjunction with the Annual ISNVD Conference of 2014.

A silent auction will also be held to benefit ISNVD. In addition, Jeff Beal, an Emmy award winning music composer, and the first person treated for CCSVI in the US at Stanford, will be playing music with friends throughout the evening.

Who: Michael Dake, M.D., ISNVD President, Annual Meeting Chair, Stanford University Mark E. Haacke, Ph.D., ISNVD Vice-President, Wayne State University, Paolo Zamboni, M.D., ISNVD Annual Meeting Chairperson, University of Ferarra, Italy, Clive Beggs, Ph.D., ISNVD Chairperson, Publication Committee, University of Bradford, U.K. and others

When: Saturday, February 8, 2014, 7-10:00pm.

Where: Marines' Memorial Club & Hotel, 609 Sutter St., San Francisco, CA 94102

Why: CCSVI is a promising, albeit controversial new treatment for Multiple Sclerosis involving opening obstructed veins with angioplasty. The research is still in its early stages, and there are many questions still unanswered. This gala event gives patients and physicians a rare opportunity to chat face-to-face with the top researchers in the field, while simultaneously supporting upcoming research. Proceeds will go directly to support ISNVD, furthering the promise of this new approach to MS & other neurological diseases.

Further information on the event can be found here: http://bit.ly/19Vlm7D
http://bit.ly/19Vlm7D Tickets can be reserved through the site above or by calling (888) 334-7495

SOURCE Annette Funicello Research Fund For Neurological Diseases, Inc

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
88%
Borrow lightly from EMA's pathway program?
4%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here